Combiflam Tablet belongs to the therapeutic classification of Non-Opioid Analgesics and Antipyretic Drugs, Non-steroidal Anti-Inflammatory Drugs (NSAIDs). The prima

Caution is advised in people with underlying sensitivity to aspirin and other pain killers. Combiflam Tablet 20's is contraindicated in children below 12 years of age under 40 kg of weight. If treatment is required for more than 3 days consult your doctor. Combiflam Tablet 20's should be taken with caution if you have an allergy to paracetamol, ibuprofen, aspirin, or other pain killers, highly sensitive reactions (asthma, lip/face/throat swelling), existing stomach ulcer or bleeding associated pain killers, blood clotting disorder, heart diseases (like congestive heart failure), kidney disease, peptic ulcer, other Active bleeding (like brain stroke bleeding), and severe dehydration (due to vomiting, diarrhoea). Liver damage might occur if taken for a longer duration as it contains paracetamol. The skin should be closely monitored as skin allergic reactions like Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have been reported with the use of Combiflam Tablet 20's. Blood pressure and cardiovascular (heart) status should be monitored closely during the treatment with Combiflam Tablet 20's especially in people affected with high blood pressure and who had a history of heart failure.